Healthnostics Provides Corporate Update
BETHESDA, Md.--Healthnostics, Inc. (Pink Sheets:HNSO), a medical and biotechnology analytics company, is pleased to provide the following update report regarding the Company's development and progress.
Special Stock Distribution
The Special Stock Distribution previously announced for shareholders of record as of March 12, 2007 is proceeding for completion in May. The Company first had to finish the share structure change in which a concurrent reverse split and a forward split of Healthnostics stock was undertaken in order to cancel shareholder accounts holding less than 100 shares. These were paid in cash equal to $.026 per share. Now that this process has been completed by our transfer agent, the Special Stock Distribution can proceed.
MedBioWeb Corp.
MedBioWeb's newly redesigned medical and biotechnology professional portal MedBioWorld.com has drawn praise from its users and has an increasing user base. New advertising and partner affiliate programs are underway. MedBioNews e-newsletter subscribers have substantially increased and there are major new sponsorship and advertising opportunities that have been produced by The Fieldstone Hill Group.
Healthnostics' MedBioWeb Corp. subsidiary continues to be in the registration process with the Securities and Exchange Commission. Previously, Healthnostics announced that the Company had filed a registration statement to spin-off MedBioWeb Corp., into a new, fully reporting company. Please Note: This spin-off equates to 100% ownership of MedBioWeb by Healthnostics shareholders. Further, as an added benefit to Healthnostics shareholders, all MedBioWeb shares will be registered and free-trading, regardless of whether shares of Healthnostics owned are free-trading or bear a restrictive legend.
Clinical Software Systems
MedGuardian, which addresses critical quality improvement issues facing hospitals today, continues to be successfully marketed to hospital associations, government and private sector hospitals generating new and viable future sales opportunities. Healthnostics' target market for MedGuardian is the 4,200 small to medium sized acute care hospitals that constitute the majority of hospitals in the U.S.
Strategy
The Company's strategy is to leverage, build or acquire compatible healthcare technologies that will create valuable business offerings for us in the healthcare and biotechnology information technology market.
"We are executing on our corporate plan through incubator spin-off initiatives such as MedBioWeb, developing continuous quality improvement opportunities with important hospital prospects, and building content and adding revenue initiatives with our major medical and biotechnology portals," said Alan Grofe, President.
For further information please visit Healthnostics www.healthnostics.com, MedBioWorld www.medbioworld.com, and FamilyMedicalNet www.familymedicalnet.com.
This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.
Contacts
SmallCapVoice.com
Stuart T. Smith, 512-267-2430
F. 512-267-2530
SSmith@SmallCapVoice.com
www.SmallCapVoice.com
or
for Healthnostics, Inc.
Jason Pollack, 561-731-2215
Special Stock Distribution
The Special Stock Distribution previously announced for shareholders of record as of March 12, 2007 is proceeding for completion in May. The Company first had to finish the share structure change in which a concurrent reverse split and a forward split of Healthnostics stock was undertaken in order to cancel shareholder accounts holding less than 100 shares. These were paid in cash equal to $.026 per share. Now that this process has been completed by our transfer agent, the Special Stock Distribution can proceed.
MedBioWeb Corp.
MedBioWeb's newly redesigned medical and biotechnology professional portal MedBioWorld.com has drawn praise from its users and has an increasing user base. New advertising and partner affiliate programs are underway. MedBioNews e-newsletter subscribers have substantially increased and there are major new sponsorship and advertising opportunities that have been produced by The Fieldstone Hill Group.
Healthnostics' MedBioWeb Corp. subsidiary continues to be in the registration process with the Securities and Exchange Commission. Previously, Healthnostics announced that the Company had filed a registration statement to spin-off MedBioWeb Corp., into a new, fully reporting company. Please Note: This spin-off equates to 100% ownership of MedBioWeb by Healthnostics shareholders. Further, as an added benefit to Healthnostics shareholders, all MedBioWeb shares will be registered and free-trading, regardless of whether shares of Healthnostics owned are free-trading or bear a restrictive legend.
Clinical Software Systems
MedGuardian, which addresses critical quality improvement issues facing hospitals today, continues to be successfully marketed to hospital associations, government and private sector hospitals generating new and viable future sales opportunities. Healthnostics' target market for MedGuardian is the 4,200 small to medium sized acute care hospitals that constitute the majority of hospitals in the U.S.
Strategy
The Company's strategy is to leverage, build or acquire compatible healthcare technologies that will create valuable business offerings for us in the healthcare and biotechnology information technology market.
"We are executing on our corporate plan through incubator spin-off initiatives such as MedBioWeb, developing continuous quality improvement opportunities with important hospital prospects, and building content and adding revenue initiatives with our major medical and biotechnology portals," said Alan Grofe, President.
For further information please visit Healthnostics www.healthnostics.com, MedBioWorld www.medbioworld.com, and FamilyMedicalNet www.familymedicalnet.com.
This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.
Contacts
SmallCapVoice.com
Stuart T. Smith, 512-267-2430
F. 512-267-2530
SSmith@SmallCapVoice.com
www.SmallCapVoice.com
or
for Healthnostics, Inc.
Jason Pollack, 561-731-2215
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.